Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VOR is expected to report earnings to fall 98.09% to -9 cents per share on August 06
Q2'26
Est.
$-0.10
Q1'26
Missed
by $5.01
Q4'25
Beat
by $84.98
Q3'25
Missed
by $121.50
Q2'25
Missed
by $4.98
The last earnings report on May 07 showed earnings per share of -511 cents, missing the estimate of -10 cents. With 545.06K shares outstanding, the current market capitalization sits at 778.11M.